Actively Recruiting

Age: 18Years +
All Genders
NCT05956236

Hip Prospective Study

Led by Societe dEtude, de Recherche et de Fabrication · Updated on 2026-04-14

5000

Participants Needed

1

Research Sites

1196 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In an evaluation report dated 2014, the HAS (Haute Autorité de Santé -French National Authority for Health) highlights that long-term clinical data on hip prostheses are needed in the context of the French healthcare system. In addition, per the European Regulation 2017/745, medical devices manufacturers shall conduct Post-Market Clinical Follow-up (PMCF) on their devices or provide a justification why PMCF is not applicable. Therefore, as part of the PMCF process of their hip prostheses, SERF wants to conduct a PMCF investigation to ensure the long-term real-life performance, safety and benefits of these prostheses. HiPS is a non-comparative, prospective, multicentric, national, 15-year follow-up clinical investigation.

CONDITIONS

Official Title

Hip Prospective Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female adults
  • Planned to be implanted with investigational medical devices per the IFUs
  • Implantation in skeletally mature adults (usually aged 60-65 and over) with extremely painful or disabled joints not improved by other treatments
  • Implantation of investigational devices as integrated systems with all components from SERF
  • Intended purpose and indication listed in the IFUs
  • Affiliated to French social security
  • Provided a dated and signed informed consent form
Not Eligible

You will not qualify if you...

  • Patient protected by a French legal measure
  • Patient unable to express consent as deemed by the investigator
  • Patient deprived of liberty or hospitalized without consent
  • Pregnant or breastfeeding women
  • Patient contraindicated to investigational device implantation per IFUs
  • Patient contraindicated to radiographic follow-up
  • Patient deemed unable to meet follow-up visits by investigator
  • Patient unable to complete self-assessment questionnaires as deemed by investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHU St Etienne

Saint-Priest-en-Jarez, France, 42270

Actively Recruiting

Loading map...

Research Team

C

Clinical department

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here